Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: Preliminary report

British Journal of Plastic Surgery

Volumn 58, Issue 4, 2005, Pages 504-510

  Lissia, Mariolissia ^a   Figus, A ^a   Rubino, C ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Immunoglobulins; IVIG; Plasma exchange; Plasmapheresis; TEN; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ATENOLOL; BARBITURIC ACID DERIVATIVE; CALCIUM CARBONATE; CAPTOPRIL; CORTICOSTEROID; DOXAZOSIN; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IG VENA N; IMMUNOGLOBULIN; INSULIN; KETOROLAC; RAMIPRIL;

ADULT; AGED; ARTICLE; CANDIDIASIS; CASE REPORT; CHRONIC KIDNEY FAILURE; CONFIDENCE INTERVAL; CONJUNCTIVITIS; CROHN DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; EYE SYNECHIA; FEMALE; GOUT; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; KERATITIS; MALE; MENINGIOMA; MORTALITY; PARENTERAL NUTRITION; PLASMAPHERESIS; PRIORITY JOURNAL; RATING SCALE; SEPSIS; SKIN BIOPSY; STANDARDIZATION; TOXIC EPIDERMAL NECROLYSIS; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PLASMAPHERESIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 18444377599     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2004.12.007     Document Type: Article

References (57)

1. A. Lyell Toxic epidermal necrolysis: An eruption rembling scalding of the skin Br J Dermatol 68 1956 361-366
2. W.J. Power M. Ghoraishi J. Merayo-Lloves C.S. Foster Analysis of the acute ophthalmic manifestations of the erythema multiforme/ Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum Ophthalmology 102 1995 1669-1676
3. P. Wolkenstein J. Revuz Toxic epidermal necrolysis Dermatol Clin 18 2000 485-495
4. J.T. Schulz R.L. Sheridan C.M. Ryan B. MacKool R.G. Tompkins A 10-year experience with toxic epidermal necrolysis J Burn Care Rehabil 21 2000 199-204
5. M. Hollyoak M.J. Mueller M.H. Desai Exfoliative and necrotizing conditions of the integument In: D.N. Herndon, editor. Total burn care 1996 WB Saunders London 432-439
6. S. Bastuji-Garin M. Zahedi J.C. Guillaume J.C. Roujeau Toxic epidermal necrolysis (Lyell's syndrome) in 77 elderly patients Age Ageing 22 1993 450-456
7. S. Honari N.S. Gibran D.M. Heimbach et al. Toxic epidermal necrolysis (TEN) in elderly patients J Burn Care Rehabil 22 2001 132-135
8. I. Garcia-Doval L. LeCleach H. Bocquet X.L. Otero J.C. Roujeau Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136 2000 323-327
9. D.N. Herndon Toxic epidermal necrolysis: A systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids J Am Coll Surg 180 1995 340-342
10. J.C. Roujeau E. Albengres S. Moritz Lymphocyte transformation test in drug-induced toxic epidermal necrolysis Int Arch Allergy Appl Immunol 78 1985 22-24
11. S. Bastuji-Garin B. Rzany R.S. Stern N.H. Shean L. Naldi J.C. Roujeau Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme Arch Dermatol 129 1993 92-96
12. S.L. Engelhardt M.J. Schurr R.B. Helgerson Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage J Burn Care Rehabil 18 1997 520-524
13. D.R. Yarbrough Experience with toxic epidermal necrolysis treated in a burn center J Burn Care Rehabil 17 1996 30-33
14. T. McGee A. Munster Toxic epidermal necrolysis syndrome: Mortality rate reduced with early referral to regional burn center Plast Reconstr Surg 102 1998 1018-1022
15. M.Z. Mofid C. Costarangos B. Bernstein L. Wong A. Munster H.C. Nousari Drug-induced linear immunoglobulin a bullous disease that clinically mimics toxic epidermal necrolysis J Burn Care Rehabil 21 2000 246-247
16. C. Paul P. Wolkenstein H. Adle Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis Br J Dermatol 134 1996 710-714
17. C. Prins F.A. Kerdel R.S. Padilla Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins Arch Dermatol 139 2003 26-32
18. I. Ducic A. Shalom W. Rising K. Nagamoto A.M. Munster Outcome of patients with toxic epidermal necrolysis revisited Plast Reconstr Surg 110 2002 768-773
19. N. Bachot J. Revuz J.C. Roujeau Intravenous Immunoglobulin treatment for Steven-Johnson syndrome and toxic epidrmal necrolysis Arch Dermatol 139 2003 33-36
20. S. Bastuji-Garin N. Fouchard M. Bertocchi J.C. Roujeau J. Revuz P. Wolkenstein SCORTEN: A severity-of-illness score for toxic epidermal necrolysis J Invest Dermatol 115 2000 149-153
21. C.C. Lund N.C. Browder The estimation of areas of burns Surg Gynecol Obstet 79 1944 352
22. J.T. Trent R.S. Kirsner P. Romanelli F.A. Kerdel Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN Arch Dermatol 139 2003 39-43
23. I. Viard P. Wehrli R. Bullani et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490-493
24. R. Abe T. Shimizu A. Shibaki H. Nakamura H. Watanabe H. Shimizu Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand Am J Pathol 162 2003 1515-1520
25. I. Viard-Leveugle R.R. Bullani P. Meda et al. Intracelleular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions J Biol Chem 278 2003 16183-16188
26. J.M. Arevalo J.A. Lorente C. Gonzales-Herrada J. Jimenez-Reyes Treatment of toxic epidermal necrolysis with Cyclosporin A J Trauma 48 2000 473-478
27. P. Jarrett M. Rademaker J. Havill H. Pullon Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor Clin Exp Dermatol 22 1997 146-147
28. P. Redondo I. de Felipe A. de la Pena J.M. Aramendia V. Vanaclocha Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine Br J Dermatol 136 1997 645-646
29. N.G. Frangogiannis I. Boridy M. Mazhar R. Mathews S. Gangopadhyay T. Cate Cyclophosphamide in toxic epidermal necrolysis South Med J 89 1996 1001-1003
30. A. Furubacke G. Berlin C. Anderson F. Sjoberg Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis? Int Care Med 25 1999 1307-1310
31. G. Sakellariou P. Koukoudis J. Karpouzas et al. Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN) Int J Artif Organs 14 1991 634-638
32. D. Kamanbroo W. Schimtz-Landgraf B.M. Czarnetzki Plasmapheresis in severe drug-induced toxic epidermal necrolysis Arch Dermatol 121 1985 1548-1549
33. G.C. Chaidemenos F. Chrysomallis K. Sombolos O. Mourellou D. Ioannides M. Papakonstantinou Plasmapheresis in toxic epidermal necrolysis Int J Dermatol 36 1997 218-221
34. C.A. Egan W.J. Grant S.E. Morris J.R. Saffle J.J. Zone Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis J Am Acad Dermatol 40 1999 458-461
35. G. Bamichas T. Natse F. Christidou et al. Plasma exchange in patients with toxic epidermal necrolysis Ther Apher 6 2002 225-228
36. P. Wolkenstein J. Latarjet J.C. Roujeau et al. Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis Lancet 352 1998 1586-1589
37. P. Paquet E. Jacob P. Damas G.E. Pièrard Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins Burns 27 2001 652-655
38. T.G. Phan R.C.W. Wong K. Crotty S. Adelstein Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin Australas J Dermatol 40 1999 153-157
39. M. Stella P. Cassano D. Bollero A. Clemente Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: Our experience Dermatology 203 2001 45-49
40. N. Bachot J.C. Roujeau Intravenous immunoglobulins in the treatment of severe drug eruptions Curr Opin Allergy Clin Immunol 3 2003 269-274
41. K.M. Brown G.M. Silver M. Halerz P. Walaszek A. Sandroni R.L. Gamelli Toxic epidermal necrolysis: Does immunoglobulin make a difference? J Burn Care Rehabil 25 2004 81-88
42. P. Paquet G.E. Pierard Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin Int J Mol Med 10 2002 145-147
43. P. Paquet P. Quatresooz G.E. Pierard Factor-XIIIa-Positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyel's syndrome): paradoxical activation in skin and rarefaction in lymph nodes Dermatology 206 2003 374-378
44. O. Correia L. Delgado I.L. Barbosa F. Campilho J. Fleming-Torrinha Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis J Am Acad Dermatol 47 2002 58-62
45. A. Nassif A. Bensussan G. Dorothee et al. Drug specific cytotoxic T-cells in the lesions of a patient with toxic epidermal necrolysis J Invest Dermatol 118 2002 728-733
46. O. Correia L. Delgado J.C. Roujeau L. Le Cleach J.A. Fleming-Torrinha Solubile interleukin 2 receptor and interleukin 1 alpha in toxic epidermal necrolysis: A comparative analysis of serum and blisters fluid samples Arch Dermatol 138 2002 29-32
47. O. Correia L. Delgado I.L. Barbosa et al. CD8+lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host-disease: Further similarities with toxic epidermal necrolysis Dermatology 203 2001 212-216
48. H. Miyauchi H. Hosokawa T. Akaeda H. Iba Y. Asada T-cell subset in drug- induced toxic epidermal necrolysis: Possible pathogenic mechanism induced by CD8-positive T cells Arch Dermatol 127 1991 851-855
49. O. Correia L. Delgado J.P. Ramos C. Resende J.A. Torrinha Cutaneous T-cell recruitment in toxic epidermal necrolysis: Further evidence of CD8+lymphocyte involvement Arch Dermatol 129 1993 466-468
50. L.J. Picker J.R. Treer T.K. Kishimoto et al. Elam-1 is an adhesion molecule for the skin homing T-cells Nature 349 1991 796-799
51. C. Mayorga M.J. Torres J.L. Corzo et al. Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin Ann Allergy Asthma Immunol 91 2003 86-91
52. P. Paquet A. Nikkels J.E. Arrese Macrophages and tumor necrosis factor alfa in toxic epidermal necrolysis Arch Dermatol 130 1994 605-608
53. J.J. Cohen R.C. Duke Apoptosis and programmed cell death in immunity Ann Rev Immunol 10 1992 267-293
54. L. Leyva M.J. Torres S. Posadas et al. Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response J Allergy Clin Immunol 105 2000 157-165
55. P. Paquet E. Jacob P. Damas G.E. Pierard Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's Syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability Crit Care Med 30 2002 2580-2583
56. J. Revuz D. Penso J.C. Roujeau et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients Arch Dermatol 123 1987 1160-1165
57. J.T. Murphy G.F. Purdue J.L. Hunt Toxic epidermal necrolysis J Burn Care Rehabil 18 1997 417-420